• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺神经内分泌肿瘤的外科治疗

Surgical Management of Pancreatic Neuroendocrine Tumors.

作者信息

Sulciner Megan L, Clancy Thomas E

机构信息

Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Cancers (Basel). 2023 Mar 28;15(7):2006. doi: 10.3390/cancers15072006.

DOI:10.3390/cancers15072006
PMID:37046665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10093271/
Abstract

Pancreatic neuroendocrine tumors (PNETs) are relatively uncommon malignancies, characterized as either functional or nonfunctional secondary to their secretion of biologically active hormones. A wide range of clinical behavior can be seen, with the primary prognostic indicator being tumor grade as defined by the Ki67 proliferation index and mitotic index. Surgery is the primary treatment modality for PNETs. While functional PNETs should undergo resection for symptom control as well as potential curative intent, nonfunctional PNETs are increasingly managed nonoperatively. There is increasing data to suggest small, nonfunctional PNETs (less than 2 cm) are appropriate follow with nonoperative active surveillance. Evidence supports surgical management of metastatic disease if possible, and occasionally even surgical management of the primary tumor in the setting of widespread metastases. In this review, we highlight the evolving surgical management of local and metastatic PNETs.

摘要

胰腺神经内分泌肿瘤(PNETs)是相对罕见的恶性肿瘤,根据其生物活性激素的分泌情况可分为功能性或非功能性。其临床表现多样,主要预后指标是由Ki67增殖指数和有丝分裂指数定义的肿瘤分级。手术是PNETs的主要治疗方式。功能性PNETs应进行切除以控制症状并可能达到治愈目的,而非功能性PNETs越来越多地采用非手术治疗。越来越多的数据表明,小的非功能性PNETs(小于2厘米)适合采用非手术积极监测随访。有证据支持在可能的情况下对转移性疾病进行手术治疗,甚至在广泛转移的情况下偶尔也对原发性肿瘤进行手术治疗。在本综述中,我们重点介绍了局部和转移性PNETs不断发展的手术治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c1/10093271/ee107f055538/cancers-15-02006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c1/10093271/2678e5c5a3fb/cancers-15-02006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c1/10093271/2e37464532ab/cancers-15-02006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c1/10093271/5cf9e8210156/cancers-15-02006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c1/10093271/ee107f055538/cancers-15-02006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c1/10093271/2678e5c5a3fb/cancers-15-02006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c1/10093271/2e37464532ab/cancers-15-02006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c1/10093271/5cf9e8210156/cancers-15-02006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c1/10093271/ee107f055538/cancers-15-02006-g004.jpg

相似文献

1
Surgical Management of Pancreatic Neuroendocrine Tumors.胰腺神经内分泌肿瘤的外科治疗
Cancers (Basel). 2023 Mar 28;15(7):2006. doi: 10.3390/cancers15072006.
2
Surgical Management of Pancreatic Neuroendocrine Tumors.胰腺神经内分泌肿瘤的外科治疗
Hematol Oncol Clin North Am. 2016 Feb;30(1):103-18. doi: 10.1016/j.hoc.2015.09.004. Epub 2015 Oct 24.
3
Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.利用 Ki-67 增殖指数、磷酸化组蛋白 H3(PHH3)和 BCL-2 提高细针抽吸术对胰腺神经内分泌肿瘤肿瘤生物学侵袭性的预测能力。
Ann Diagn Pathol. 2023 Aug;65:152149. doi: 10.1016/j.anndiagpath.2023.152149. Epub 2023 Apr 21.
4
Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.散发性切除的小(≤2厘米)无功能胰腺神经内分泌肿瘤的恶性风险及预后
Gland Surg. 2021 Jan;10(1):219-232. doi: 10.21037/gs-20-582.
5
Surgical management of pancreatic neuroendocrine tumors: an introduction.胰腺神经内分泌肿瘤的外科治疗:引言。
Expert Rev Anticancer Ther. 2019 Dec;19(12):1089-1100. doi: 10.1080/14737140.2019.1703677. Epub 2019 Dec 17.
6
Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.偶然发现的小型无功能胰腺神经内分泌肿瘤的手术切除与观察等待治疗
Surgery. 2016 Jan;159(1):302-9. doi: 10.1016/j.surg.2015.10.013. Epub 2015 Nov 4.
7
The Role of Surgery for Pancreatic Neuroendocrine Tumors.外科手术在胰腺神经内分泌肿瘤治疗中的作用。
Anticancer Res. 2022 Feb;42(2):629-639. doi: 10.21873/anticanres.15520.
8
Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET).散发性小(≤2 cm)无功能性胰腺神经内分泌肿瘤的外科治疗:中国神经内分泌肿瘤研究组(CSNET)共识声明
Int J Oncol. 2017 Feb;50(2):567-574. doi: 10.3892/ijo.2016.3826. Epub 2016 Dec 29.
9
Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis.胰腺小神经内分泌肿瘤的特征及侵袭转移的危险因素。
Front Endocrinol (Lausanne). 2023 Mar 20;14:1140873. doi: 10.3389/fendo.2023.1140873. eCollection 2023.
10
Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports.发病率、进展情况及当前治疗:结节性硬化症相关非功能性胰腺神经内分泌肿瘤16例新病例报告及与既往报告的比较
Front Neurol. 2021 Apr 9;12:627672. doi: 10.3389/fneur.2021.627672. eCollection 2021.

引用本文的文献

1
Surgical Versus Nonsurgical Management of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.胰腺神经内分泌肿瘤的手术治疗与非手术治疗:一项系统评价与Meta分析
Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17819-3.
2
Collision tumors. A patient with synchronous distinct pancreatic adenocarcinoma and neuroendocrine tumors. Case report.碰撞瘤。一名患有同步性不同类型胰腺腺癌和神经内分泌肿瘤的患者。病例报告。
Int J Surg Case Rep. 2025 Aug;133:111572. doi: 10.1016/j.ijscr.2025.111572. Epub 2025 Jul 3.
3
When is belzutifan the right option for von Hippel-Lindau disease-associated hemangioblastomas?-a critical review of LITESPARK-004 results.

本文引用的文献

1
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study.原发性肿瘤切除对IV期1级和2级胰腺神经内分泌肿瘤的益处:一项倾向评分匹配队列研究。
Ann Surg Open. 2022 Mar 14;3(1):e151. doi: 10.1097/AS9.0000000000000151. eCollection 2022 Mar.
2
Characterizing gastrointestinal dysfunction after pancreatic resection: a single-center retrospective study.胰腺切除术后胃肠功能障碍的特征:一项单中心回顾性研究。
BMC Gastroenterol. 2022 Nov 26;22(1):488. doi: 10.1186/s12876-022-02565-7.
3
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial.
何时贝佐替凡(belzutifan)是与希佩尔-林道病相关的血管母细胞瘤的合适选择?——对LITESPARK-004结果的批判性综述
Transl Cancer Res. 2025 May 30;14(5):2558-2562. doi: 10.21037/tcr-2024-2478. Epub 2025 May 13.
4
Surufatinib related nephrotic syndrome in a pancreatic neuroendocrine tumor: a case report and review of literature.舒尼替尼相关的胰腺神经内分泌肿瘤肾病综合征:一例报告并文献复习
Front Oncol. 2025 May 21;15:1546217. doi: 10.3389/fonc.2025.1546217. eCollection 2025.
5
Treatment of Pancreatic Neuroendocrine Tumors: Beyond Traditional Surgery and Targeted Therapy.胰腺神经内分泌肿瘤的治疗:超越传统手术和靶向治疗
J Clin Med. 2025 May 13;14(10):3389. doi: 10.3390/jcm14103389.
6
NON-FUNCTIONING SPORADIC PANCREATIC NEUROENDOCRINE TUMOR IS AN INDEPENDENT RISK FACTOR FOR RECURRENCE AFTER SURGICAL TREATMENT.无功能散发性胰腺神经内分泌肿瘤是手术治疗后复发的独立危险因素。
Arq Bras Cir Dig. 2025 Jan 20;37:e1857. doi: 10.1590/0102-6720202400063e1857. eCollection 2025.
7
Recurrence and treatment trends of pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤的复发及治疗趋势
Surgery. 2025 Jan;177:108835. doi: 10.1016/j.surg.2024.05.051. Epub 2024 Oct 4.
8
Prognostic Nomograms for Patients With NF-Pan-NET After Pancreatectomy: A Retrospective Analysis Based on SEER Database.基于 SEER 数据库的胰腺切除术后 NF-Pan-NET 患者预后列线图:一项回顾性分析。
Cancer Rep (Hoboken). 2024 Sep;7(9):e2165. doi: 10.1002/cnr2.2165.
9
The association between non-HDL cholesterol and high-grade pancreatic neuroendocrine neoplasms.非高密度脂蛋白胆固醇与高级别胰腺神经内分泌肿瘤之间的关系。
Endocrine. 2024 Nov;86(2):584-591. doi: 10.1007/s12020-024-03910-4. Epub 2024 Jun 6.
10
Multivisceral resection of nonfunctional pancreatic neuroendocrine neoplasm with nearby organ invasion: a case report.多脏器切除术治疗伴有邻近器官侵犯的无功能胰腺神经内分泌肿瘤:病例报告。
Front Endocrinol (Lausanne). 2023 Sep 26;14:1236685. doi: 10.3389/fendo.2023.1236685. eCollection 2023.
直径不超过2厘米的无症状散发性无功能胰腺神经内分泌肿瘤的管理:前瞻性ASPEN试验的中期分析
Br J Surg. 2022 Nov 22;109(12):1186-1190. doi: 10.1093/bjs/znac267.
4
Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for management of pancreatic lesions: a systematic review and meta-analysis.内镜超声引导下射频消融治疗胰腺病变的疗效与安全性:一项系统评价和Meta分析
Transl Gastroenterol Hepatol. 2022 Jul 25;7:30. doi: 10.21037/tgh-20-84. eCollection 2022.
5
Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients.微创与开腹胰腺神经内分泌肿瘤切除术:1023 例多机构 10 年经验。
J Am Coll Surg. 2022 Aug 1;235(2):315-330. doi: 10.1097/XCS.0000000000000257. Epub 2022 May 2.
6
Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients.预测胰腺神经内分泌肿瘤的进展、复发和生存:单中心 174 例患者分析。
Front Endocrinol (Lausanne). 2022 Jun 28;13:925632. doi: 10.3389/fendo.2022.925632. eCollection 2022.
7
Surgery or active surveillance for pNETs < 2 cm: Preliminary results from a single center Brazilian cohort.对于 < 2 cm 的胰腺神经内分泌肿瘤(pNETs),采用手术或主动监测:来自巴西单中心队列的初步结果。
J Surg Oncol. 2022 Jul;126(1):168-174. doi: 10.1002/jso.26931.
8
Preoperative therapy for pancreatic adenocarcinoma-precision beyond anatomy.胰腺癌的术前治疗——超越解剖学的精准治疗。
Cancer. 2022 Aug 15;128(16):3041-3056. doi: 10.1002/cncr.34273. Epub 2022 Jun 9.
9
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.PD-1 阻断在错配修复缺陷、局部晚期直肠癌中的应用。
N Engl J Med. 2022 Jun 23;386(25):2363-2376. doi: 10.1056/NEJMoa2201445. Epub 2022 Jun 5.
10
Enucleation Is a Feasible Procedure for Well-Differentiated pNEN-A Matched Pair Analysis.眼球摘除术是一种用于高分化胰腺神经内分泌肿瘤的可行手术——配对分析
Cancers (Basel). 2022 May 23;14(10):2570. doi: 10.3390/cancers14102570.